Search

Displaying results 9181 - 9190 of 10000 in total
  1. Drug

    Sanfetrinem cilexetil

    go.drugbank.com/drugs/DB19135
    Investigational

    Sanfetrinem cilexetil is under investigation in clinical trial NCT05388448 (EBA, Safety and Tolerability of Sanfetrinem Cilexetil).

  2. Drug

    Acemannan

    go.drugbank.com/drugs/DB19224
    Investigational

    Acemannan is under investigation in clinical trial NCT03250923 (Celagace™ Orarinse Solution for Treatment of Candidiasis).

  3. Drug

    Pavinetant

    go.drugbank.com/drugs/DB11692
    Investigational

    Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.

  4. Drug

    Mitoglitazone

    go.drugbank.com/drugs/DB11721
    Investigational

    Mitoglitazone has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.

  5. Drug

    Fevipiprant

    go.drugbank.com/drugs/DB12011
    Investigational

    Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.

  6. Drug

    Ozoralizumab

    go.drugbank.com/drugs/DB12014
    Investigational

    Ozoralizumab has been used in trials studying the treatment of Rheumatoid Arthritis and Active Rheumatoid Arthritis.

  7. Drug

    Atagabalin

    go.drugbank.com/drugs/DB12032
    Investigational

    Atagabalin has been used in trials studying the treatment of Insomnia, Primary Insomnia, and Nonrestorative Sleep.

  8. Drug

    ORM-12741

    go.drugbank.com/drugs/DB12057
    Investigational

    ORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.

  9. Drug

    ORG-25935

    go.drugbank.com/drugs/DB12220
    Investigational

    Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

  10. Drug

    Brilanestrant

    go.drugbank.com/drugs/DB12253
    Investigational

    ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.